FCGR1A and ocular melanoma: Our results finally identified a new set of novel biomarkers and important molecular targets, including 3 TF-target gene pairs (SP1-LSP1, SPI1-FCGR1A, and STAT1-FCGR1A), 3 structural proteins of NETs (MPO, ELANE, and CAMP), and 6 other hub proteins (TP53, IL4, HP, SOCS3, FOS, and CD86), which might play essential biological roles during the progression of VTE in OM patients.